# Cannabinoid Receptor (CB1) Agonist Treatment in Severe Chronic Anorexia Nervosa

> **NCT00760695** · PHASE3 · COMPLETED · sponsor: **Odense University Hospital** · enrollment: 24 (actual)

## Conditions studied

- Anorexia Nervosa

## Interventions

- **DRUG:** dronabinol
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00760695
- **Lead sponsor:** Odense University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2013-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00760695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00760695, "Cannabinoid Receptor (CB1) Agonist Treatment in Severe Chronic Anorexia Nervosa". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00760695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*